Police in Vancouver will be allowed to light up a joint when they are off-duty
Compared to the rules that have been established for the United States military, Canada's cannabis regulations are somewhat surprising
Cannabis is legal in Canada, but supply is dry
Failure to meet consumer demand with a restricted supply means that illicit substances will continue to be dealt outside of the legal system
Cannabis company files FDA application to kick-start clinical trials on cannabis to treat Huntington’s
MMJ wants to develop a cannabis-based medicine for patients with Huntington's disease and multiple sclerosis
Colorado cannabis cultivators want specific organic-like destinations for their crops
Pesticides are a serious concern for medical patients, whose immune systems may be compromised if they are exposed to impurities
Seniors constitute one of the fastest-growing groups of cannabis consumers in the U.S.
Based on the results of a survey carried out from 2006-2013, the percentage of adults who had used cannabis within the last year grew by a staggering 250 percent
There’s still a few things to figure out about cannabis legalization in Canada
With legalization right around the corner, Canada's cannabis regulations are somewhat hazy
UCSD researchers will conduct study on cannabis to treat Essential Tremor (ET)
The double-blind, placebo-control, cross-over clinical trial will enroll 16 adult participants who have been diagnosed with ET by a movement disorder neurologist
Individuals affected by the War on Drugs patiently wait for cannabis permits in San Francisco
Over 240 applications are currently in the review stage
Former president of NYSE advises investors to steer clear of Tilray (for now, at least)
Farley thinks it's a risky move for investors, until an increased number of cannabis companies start trading on top U.S. exchanges
Louisiana regulators lift patient cap on the state’s medical cannabis program
During the meeting of the State Board of Medical Examiners, regulators voted 8-1 to tackle the problem
Former U.S. Attorney describes cannabis’ Schedule 1 classification as “absurd”
Grissom’s passion for pot prompted him to visit the NORML office in Washington, before he resigned from his position as U.S. Attorney